CLYM
Valerie Morisset
Executive Vice President, Research and Development and Chief Scientific Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Climb Bio, Inc. (CLYM)
Proxy statement
Start not stated–2024-08-23
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Climb Bio, Inc. (CLYM) | Former Executive Vice President, Research and Development and Chief Scientific Officer | $358,066 | $2,235,295 |
| 2023 | Climb Bio, Inc. (CLYM) | Former Executive Vice President, Research and Development and Chief Scientific Officer | $510,853 | $1,077,620 |
| 2022 | Climb Bio, Inc. (CLYM) | — | $399,916 | $1,989,782 |
| 2021 | Climb Bio, Inc. (CLYM) | — | $347,133 | $2,525,721 |
| 2020 | Climb Bio, Inc. (CLYM) | — | $324,128 | $905,460 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.